- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Corona Remedies IPO
₹1,438.40
+35.44% on listing
Listing-day close · NSE · 15 Dec 2025 · issue price ₹1,062
Corona Remedies’ ₹655 crore IPO was priced at ₹1,062 a share. It listed on the NSE on 15 Dec 2025 and closed its first day at ₹1,438.40, up 35.44% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹655 Cr
- Fresh issue
- —
- Offer for sale
- ₹655 Cr
- Lot size
- 14 shares
- Minimum investment
- ₹14,868
- Face value
- ₹10
- Registrar
- Bigshare Services
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 101.01× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹6,495 Cr
- P/E (post-issue)
- 35.1
- EPS (post-issue)
- ₹30.21
- Price to book
- 10.7
- ROE
- 27.50%
- ROCE
- 41.32%
- Debt to equity
- 0.10
- EBITDA margin
- 20.55%
- PAT margin
- 12.49%
- Promoter holding
- 72.50% → 69.00%
Financials as of 31 Mar 2025, from the offer documents.
Listing
- Listing date
- 15 Dec 2025
- Issue price
- ₹1,062
- Open
- ₹1,470.00
- High
- ₹1,497.80
- Low
- ₹1,413.00
- Close
- ₹1,438.40
Listing day on the NSE. The close was +35.44% on the issue price.
FAQs
When did the Corona Remedies IPO open and close?
It opened on 8 Dec 2025 and closed on 10 Dec 2025.
What was the Corona Remedies IPO price?
The price band was ₹1,008–1,062 a share. The final issue price was ₹1,062.
What is the lot size and minimum investment?
One lot is 14 shares, ₹14,868 at ₹1,062 a share. Retail investors apply in whole lots.
How much did Corona Remedies raise?
₹655 crore: ₹655 crore offered by existing shareholders.
How many times was the Corona Remedies IPO subscribed?
101.01 times overall.
How did Corona Remedies list?
It listed on the NSE on 15 Dec 2025 at ₹1,470.00 and closed the day at ₹1,438.40, up 35.44% on the ₹1,062 issue price.
Who is the registrar of the Corona Remedies IPO?
Bigshare Services handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app